Jump to content

Recommended Posts

carolelisabeth
Posted

Hi, my husband has just had 2 mri scans which show a lesion on the body of the pancreas and a possible 2 smAll lesions on the liver, which they are not sure if they are cancerous( but probably) he is going fora biopsy.my problem is they say that eve if the biopsy comes back negative it wouldn't necessary mean they are not cancerous and would do another biopsy to make sure. These seems very time wasting to me has anyone else been in this position. Some advice pleaae

Posted

Hi Carolelisabeth, I had something similar where a lesion was discivered on my Pancreas (Devember 2012) using ultra sound and a CT scan. I was lined up for a chemo assesment before the biopsy was done. It was a good call and avoided delays as they were pretty sure it was cancerous. The biopsy results came back just before chemo started as inconclusive.... No cancer could be identified. However, this is apparently not that unusual and the consensus of the Multidisciplinary Team team was that the lesion was acting in a cancerous manner and was treated accordingly. The fact that I responded well to the chemo is the proof that the thing is actually cancerous.


Hope this is of use!


Steve

Posted

Just to echo Steve, I had two biopsies plus cell brushings when the stent was fitted. All came back indeterminate though the surgeon veered towards Cholangiocarcinoma. In the event my oncologist thought pancreatic more likely which led to me having Folfirinox with good response so far.

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. By using our forums you agree to our Terms of Use and Privacy Policy.